Prognostic differences between atrial fibrillation and atrial flutter - 26/08/11
Doi : 10.1016/j.amjcard.2003.11.042
Paul Lelorier, MD a, ⁎ 
, Karin H. Humphries, MBA, DSc b, Andrew Krahn, MD a, Stuart J. Connolly, MD d, Mario Talajic, MD g, Martin Green, MD e, Robert Sheldon, MD, PhD f, Paul Dorian, MD h, David Newman, MD h, Charles R. Kerr, MD c, Raymond Yee, MD a, George J. Klein, MD a
, Karin H. Humphries, MBA, DSc b, Andrew Krahn, MD a, Stuart J. Connolly, MD d, Mario Talajic, MD g, Martin Green, MD e, Robert Sheldon, MD, PhD f, Paul Dorian, MD h, David Newman, MD h, Charles R. Kerr, MD c, Raymond Yee, MD a, George J. Klein, MD a a Division of Cardiology, University of Western Ontario, London, Ontario, Canada
b Center for Health Evaluation & Outcome Sciences, Vancouver, British Columbia, Canada
c Division of Cardiology, University of British Columbia, Vancouver, British Columbia, Canada
d Division of Cardiology, McMaster University, Hamiltion, Ontario, Canada
e Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada
f Division of Cardiology, University of Calgary, Calgary, Alberta, Canada
g Montreal Heart Institute, Montreal, Quebec, Canada
h Division of Cardiology, St. Michael's Hospital, Toronto, Ontario, Canada
*Dr. LeLorier's address is: Section of Cardiology, Boston University School of Medicine, Boston Medical Center, 88 East Newton Street, Boston, Massachusetts 02118–2393, USA
Abstract |
This report presents the outcome of a cohort of 94 patients with atrial fibrillation from the Canadian Registry of Atrial Fibrillation, in which we paid particular attention to the probability of stroke and death. We also evaluated warfarin use over time and compared left atrial dimensions in patients with atrial flutter with those with atrial fibrilliation.
Le texte complet de cet article est disponible en PDF. | This research was supported by an unrestricted grant from Procter and Gamble Pharmaceutical Canada Inc., Mason, Ohio. |
© 2004
Excerpta Medica Inc. Tous droits réservés.
Vol 93 - N° 5
P. 647-649 - mars 2004 Retour au numéro
Article précédent
- Usefulness of a ventricular extrastimulus from the summit of the ventricular septum in diagnosis of septal accessory pathway in patients with supraventricular tachycardia
- Takehiko Matsushita, Nitish Badhwar, Kathryn K Collins, George F Van Hare, Gaetano Barbato, Byron K Lee, Randall J Lee, Melvin M Scheinman
- Influence of l-arginine and vitamin C on the autonomic nervous system in chronic heart failure secondary to ischemic cardiomyopathy
- Gianfranco Piccirillo, Quaglione Raffaele, Filippo Fimognari, Antonio Moisè, Malavasi Mario, Marco Lionetti, Camilla Naso, Silvia Di Carlo, Marialuce Nocco, Damiano Magrì
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?